These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 5812227)

  • 1. Beta-aminopropionohydroxamic acids and beta-aminopropionic esters with hypotensive properties.
    Coutts RT; Midha KK; Prasad K
    J Med Chem; 1969 Sep; 12(5):940-1. PubMed ID: 5812227
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthesis and properties of some hypotensive N-alkylaminopropionic esters and N,N-dialkylaminopropionic esters and their hydroxamic acids.
    Coutts RT; Hubbard JW; Midha KK; Prasad K
    J Pharm Sci; 1971 Jan; 60(1):28-33. PubMed ID: 5548238
    [No Abstract]   [Full Text] [Related]  

  • 3. Potential hypotensive compounds: substituted 3-aminopropionates and 3-aminopropionohydroxamic acids.
    Biggs DF; Coutts RT; Selley ML; Towill GA
    J Pharm Sci; 1972 Nov; 61(11):1739-45. PubMed ID: 4405723
    [No Abstract]   [Full Text] [Related]  

  • 4. 2-methyl-3-(4-phenylpiperidino)propionohydroxamic acid hydrochloride--a new hypotensive agent.
    Midha KK; Coutts RT; Hubbard JW; Prasad K
    Eur J Pharmacol; 1970 Jul; 11(1):48-55. PubMed ID: 5431115
    [No Abstract]   [Full Text] [Related]  

  • 5. Quinine-like actions of two 2-amino-2-phenol alkyl derivatives.
    Huidobro F; Lewin J; Huidobro JP; Garbarino JA; Samaniego E
    Arch Int Pharmacodyn Ther; 1969 Nov; 182(1):49-58. PubMed ID: 5365239
    [No Abstract]   [Full Text] [Related]  

  • 6. The synthesis, disposition and excretion of tritiated methyl-3-aminopropionates and 3-aminopropionohydroxamic acids.
    Wiebe LI; Coutts RT; Noujaim AA
    Arzneimittelforschung; 1973 Mar; 23(3):466-8. PubMed ID: 4740137
    [No Abstract]   [Full Text] [Related]  

  • 7. Research on the connections of isoindole derivatives and ethyl esters of formic, acetic and propionic acids.
    Kossakowski J; Struga M; Starościak BJ; Maciag IE
    Acta Pol Pharm; 2004; 61(5):367-71. PubMed ID: 15747693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structures of the naturally occurring hydroxamic acids, fusarinines A and B.
    Sayer JM; Emery TF
    Biochemistry; 1968 Jan; 7(1):184-90. PubMed ID: 4320437
    [No Abstract]   [Full Text] [Related]  

  • 9. Biochemical formation and pharmacological, toxicological, and pathological properties of hydroxylamines and hydroxamic acids.
    Weisburger JH; Weisburger EK
    Pharmacol Rev; 1973 Mar; 25(1):1-66. PubMed ID: 4571258
    [No Abstract]   [Full Text] [Related]  

  • 10. 3-Methyl pyrrole-2,4-dicarboxylic acid 2-propyl ester 4-(1,2,2-trimethyl-propyl) ester: an exploration of the C-2 position. Part I.
    Micheli F; Di Fabio R; Benedetti R; Capelli AM; Cavallini P; Cavanni P; Davalli S; Donati D; Feriani A; Gehanne S; Hamdan M; Maffeis M; Sabbatini FM; Tranquillini ME; Viziano MV
    Farmaco; 2004 Mar; 59(3):175-83. PubMed ID: 14987980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Substituted hydroxylamine derivatives acting on the central nervous system].
    Szilágyi G; Kasztreiner E; Kovács K; Borsy J
    Acta Pharm Hung; 1975 Mar; 45(2):49-65. PubMed ID: 1130203
    [No Abstract]   [Full Text] [Related]  

  • 12. Thiol esters. I. Kinetic study of the formation of 2-dimethylaminoethanethiol propionate.
    Hussain A; Schurman P
    J Pharm Sci; 1969 Jun; 58(6):684-7. PubMed ID: 5808110
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of ester groups on the haemolytic action of sapogenins. II. Esterification with bifunctional acids.
    Segal R; Milo-Goldzweig I; Schupper H; Zaitschek DV
    Biochem Pharmacol; 1970 Aug; 19(8):2501-7. PubMed ID: 5520607
    [No Abstract]   [Full Text] [Related]  

  • 14. [Synthesis of some piperidyl esters of acetyltropic and diphenylacetic acid].
    Biniecki S; Gutkowska B; Herold F
    Acta Pol Pharm; 1969; 26(3):201-7. PubMed ID: 5801239
    [No Abstract]   [Full Text] [Related]  

  • 15. Hypotensive, antiadrenergic, and antihistaminic 3-substituted 2-methyl- (or 2-phenyl-) 4(3H)-quinazolones.
    Hayao S; Havera HJ; Strycker WG
    J Med Chem; 1969 Sep; 12(5):936-8. PubMed ID: 5812225
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification and evaluation of O-alkyl substituted hydroxamic acids as potent in vitro inhibitors of the hepatic glycine cleavage system and investigation of their action on in vivo central nervous system glycine concentration.
    Johnson G; Boxer PA; Drummond JT; Boyd DK; Anderson RJ
    Arzneimittelforschung; 1989 Apr; 39(4):432-7. PubMed ID: 2751729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacology of a new potent analgesic].
    Herrmann M; Steinbrecher W; Heldt W
    Arzneimittelforschung; 1970 Aug; 20(8):977-83. PubMed ID: 5536518
    [No Abstract]   [Full Text] [Related]  

  • 18. Some aspects of the pharmacology of valyl-beta-(pyrazolyl-3)-L-alanyl6-angiotensin II.
    Hageman WE; Hofmann K; Ertel RJ; Buckley JP
    J Pharmacol Exp Ther; 1969 Aug; 168(2):295-302. PubMed ID: 4308499
    [No Abstract]   [Full Text] [Related]  

  • 19. Preparation and some properties of stable and carbon-14 and tritium-labeled short-chain aliphatic hydroxamic acids.
    Fishbein WN; Daly J; Streeter CL
    Anal Biochem; 1969 Apr; 28(1):13-24. PubMed ID: 5781405
    [No Abstract]   [Full Text] [Related]  

  • 20. [On the structure-effect-relations in cyclic acetylcholine analogues of the aminophenol-series].
    Mutschler E; Wassermann O; Woog H
    Arzneimittelforschung; 1967 Jul; 17(7):837-41. PubMed ID: 5632841
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.